This Article Full Text Full Text (PDF) All Versions of this Article: 119/1/9    most recent CIRCULATIONAHA.108.824532v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Safar, M. E. Articles by Blacher, J. Search for Related Content PubMed PubMed Citation Articles by Safar, M. E. Articles by Blacher, J. Related Collections Clinical Studies

(Circulation. 2009;119:9-12.)
© 2009 American Heart Association, Inc.

Editorial

Statins, Central Blood Pressure, and Blood Pressure Amplification

From the Université Paris Descartes; Assistance Publique-Hôpitaux de Paris; Hotel-Dieu Centre de Diagnostic et de Thérapeutique, Paris, France (M.E.S., J.B.); and the Hypertension Center, 3rd Department of Internal Medicine, Sotiria Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece (A.D.P.).

Correspondence to Professor Michel Safar, Centre de Diagnostic et de Thérapeutique, Hôtel-Dieu, 1, place du Parvis Notre-Dame, 75181 Paris Cedex 04, France. E-mail michel.safar@htd.aphp.fr

Key Words: Editorials • pulse pressure • cardiovascular diseases • statins

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
It is well established that blood pressure (BP) differs markedly between peripheral (brachial) and central arteries (aorta).¹ As the pressure wave travels distally from the heart, mean BP and diastolic BP decrease slightly (1 to 2 mmHg), but a gradual and significant increase of systolic BP (SBP) and pulse pressure (PP) occurs. This phenomenon is called BP amplification.¹ The development of commercially available devices for the assessment of central BP has boosted this field of clinical research.^1–3 Numerous studies have shown the close pathophysiological connection between central BP and cardiovascular diseases^1–4 and have highlighted the ability of central BP to provide complementary data on cardiovascular risk beyond that provided by brachial BP.^2–6

Article p 53

In the present issue of Circulation,⁷ data from the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA, a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]l^8,9) on the effect of statins on central BP is presented. Before commenting on the available data, we briefly summarize the pathophysiology of PP amplification. Finally, we discuss potential strategies based on central hemodynamics that will hopefully improve cardiovascular risk assessment and reduction.

	Pathophysiology of BP Amplification and Cardiovascular Diseases

 
As a consequence of the pulsatile nature of blood flow and of the presence of arterial stiffness/diameter gradient along the arterial tree, pressure wave reflections arise at various sites of the arterial bed.¹ The backward-traveling reflected wave sums up with the forward-traveling wave, forming the actual pressure waveform (Figure 1a). Whereas in healthy young subjects the average aortic SBP is 100 to 110 mm Hg, at . . . [Full Text of this Article]

This article has been cited by other articles:

				A. P. Avolio, L. M. Van Bortel, P. Boutouyrie, J. R. Cockcroft, C. M. McEniery, A. D. Protogerou, M. J. Roman, M. E. Safar, P. Segers, and H. Smulyan Role of Pulse Pressure Amplification in Arterial Hypertension: Experts' Opinion and Review of the Data Hypertension, August 1, 2009; 54(2): 375 - 383. [Full Text] [PDF]